Relations between subclinical disease markers and type 2 diabetes,metabolic syndrome, and incident cardiovascular disease: The Jackson heart study

Diabetes Care

Volumn 38, Issue 6, 2015, Pages 1082-1088

  Xanthakis, Vanessa ^a,b,c   Sung, Jung Hye ^d   Samdarshi, Tandaw E ^e   Hill, Alethea N ^d   Musani, Solomon K ^e   Sims, Mario ^e   Ghraibeh, Kamel A ^e   Liebson, Philip R ^f   Taylor, Herman A ^e   Vasan, Ramachandran S ^a,c   Fox, Ervin R ^e  

^a FRAMINGHAM HEART STUDY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JACKSON STATE UNIVERSITY   (United States)

^e UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^f RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMMUNITY SAMPLE; CONTROLLED STUDY; CORONARY ARTERY CALCIUM SCORE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK POPULATION; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROGNOSIS; PROSPECTIVE STUDY; AFRICAN AMERICAN; AGED; ALBUMINURIA; COMPLICATION; DIABETIC ANGIOPATHY; EPIDEMIOLOGY; ETHNOLOGY; MIDDLE AGED; UNITED STATES;

AFRICAN AMERICANS; AGED; ALBUMINURIA; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; METABOLIC SYNDROME X; MIDDLE AGED; UNITED STATES;

EID: 84962446672     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-2460     Document Type: Article

References (18)

1. Go AS, Mozaffarian D, Roger VL, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014;129:e28-e292.
2. Ingelsson E, Sullivan LM, Murabito JM, et al. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes. Diabetes 2007;56:1718-1726.
3. Malik S, Budoff MJ, Katz R, et al. Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: The Multi-Ethnic Study of Atherosclerosis. Diabetes Care 2011;34: 2285-2290.
4. Bild DE, Detrano R, Peterson D, et al. Ethnic differences in coronary calcification: The Multi- Ethnic Study of Atherosclerosis (MESA). Circulation 2005;111:1313-1320.
5. Kronmal RA, McClelland RL, Detrano R, et al. Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2007;115:2722-2730.
6. Orakzai SH, Orakzai RH, Nasir K, et al. Subclinical coronary atherosclerosis: racial profiling is necessary! Am Heart J 2006;152:819-827.
7. Budoff MJ, Nasir K, Mao S, et al. Ethnic differences of the presence and severity of coronary atherosclerosis. Atherosclerosis 2006;187:343-350.
8. Wagenknecht LE, Divers J, Bertoni AG, et al. Correlates of coronary artery calcified plaque in blacks and whites with type 2 diabetes. Ann Epidemiol 2011;21:34-41.
9. Nasir K, Shaw LJ, Liu ST, et al. Ethnic differences in the prognostic value of coronary artery calcification for all-cause mortality. J Am Coll Cardiol 2007;50:953-960.
10. Taylor HA Jr. The Jackson Heart Study: an overview. Ethn Dis 2005;15(Suppl. 6):S6-S13.
11. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433- 438.
12. Hoffmann U, Brady TJ, Muller J. Cardiology patient page. Use of new imaging techniques to screen for coronary artery disease. Circulation 2003;108:e50-e53.
13. Tullos BW, Sung JH, Lee JE, Criqui MH, Mitchell ME, Taylor HA. Ankle-brachial index (ABI), abdominal aortic calcification (AAC), and coronary artery calcification (CAC): The Jackson Heart Study. Int J Cardiovasc Imaging 2013;29: 891-897.
14. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-458.
15. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH; de SG. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995;25:1056- 1062.
16. Samdarshi TE, Taylor HA, Edwards DQ, et al. Distribution and determinants of Dopplerderived diastolic flowindices inAfrican Americans: The Jackson Heart Study (JHS). Am Heart J 2009; 158:209-216.
17. Keku E, Rosamond W, Taylor HA, et al. Cardiovascular disease event classification in the Jackson Heart Study: methods and procedures. Ethn Dis 2005;15(4 Suppl. 6):S6-S62, 70.
18. Gopal A, Nasir K, Liu ST, Flores FR, Chen L, Budoff MJ. Coronary calcium progression rates with a zero initial score by electron beam tomography. Int J Cardiol 2007;117:227-231.